American Money Management, LLC Biogen Inc. Transaction History

American Money Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $263,302 - $411,836	-1,215 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $9,104 - $12,876	-35 Reduced 2.8%	1,215 $333,000
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $22,492 - $26,375	-80 Reduced 6.02%	1,250 $391,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,330	1,330 $361,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of American Money Management, LLC, based on Form 13F filings with the SEC.

Stay updated on American Money Management, LLC with notifications on news.